Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2013
OPERATING ACTIVITIES      
Net loss $ (15,197,865) $ (9,130,664) $ (5,652,488)
Adjustments to reconcile net loss to net cash used by operating activities:      
Common stock issued for services 635,288   270,167
Warrants issued for services 8,559 1,177,095 335,869
Stock option expense 3,579,788 2,074,487 746,262
Change in fair value of contingent consideration (2,637,756)    
Loss on derivative liability     1,117,642
Share in losses on investment in joint venture 103,143 10,643  
Depreciation 40,623 17,850 13,356
Amortization of intangible assets 1,138,631 448,456 77,789
Impairment of Intangibles 338,906    
Gain on settlement of accounts payable (40,636)    
Changes in operating assets and liabilities      
Prepaid expenses and deposits 7,214 105,823 236,492
Accounts payable and accrued expenses 1,331,120 (63,822) 165,224
Net Cash Used in Operating Activities (10,692,985) (5,360,132) (2,689,687)
INVESTING ACTIVITIES      
Acquisition of SKS Ocular's assets   (3,500,000)  
Investment in joint venture (100,000) (13,786)  
Purchase of property and equipment (184,951) (1,083)  
Net Cash Used in Investing Activities (284,951) (3,514,869)  
FINANCING ACTIVITIES      
Proceeds for issuance of common stock for cash 26,582,998 16,876,000  
Proceeds from warrants exercised for cash 80,003 260,752 5,251,755
Repayments of short-term notes payable (208,236) (164,152) (71,586)
Net Cash Provided by Financing Activities 26,454,765 16,972,600 5,180,169
NET CHANGE IN CASH 15,476,829 8,097,599 2,490,482
CASH AT BEGINNING OF PERIOD 13,220,494 5,122,895 2,632,413
CASH AT END OF PERIOD 28,697,323 13,220,494 5,122,895
CASH PAID FOR:      
Interest 5,977 5,576 4,192
NON CASH FINANCING ACTIVITIES:      
Reclassification of derivative liability to permanent equity     1,886,338
Financing of insurance premiums through issuance of short term notes $ 212,400 194,000 63,600
Conversion of preferred for common stock   50 $ 508
Common stock issued to acquire intangible assets 10,180,224
Common stock issued to settle accounts payable $ 50,000 $ 50,000